Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors
The purpose of this protocol is to create a repository of blood samples from patients diagnosed with primary and metastatic brain tumors who are being seen in the Department of Radiation Oncology at Duke Cancer Center.
Brain Tumor, Primary|Brain Metastases, Adult
Number of circulating immune cells in peripheral blood, reported as mean +/- standard deviation, 6 weeks post radiation therapy
Repository blood samples will be used to study the association of circulating biomarkers with radiation therapy outcomes.